From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves new Type 2 diabetes treatment

from Pharmacy Times

The FDA recently approved Boehringer Ingelheim and Lilly's empagliflozin and linagliptin as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes who can be treated with both of the drug's active ingredients individually. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063